Frederiksstaden Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 25630483
Frederiksgade 11, 1265 København K
tel: 36495500
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 043.72 | - 666.38 | 13.10 | -79.85 | -39.06 |
| Employee benefit expenses | -3 303.97 | -1 351.63 | |||
| Total depreciation | -60.29 | -37.39 | |||
| EBIT | -1 320.54 | -2 457.94 | 13.10 | -79.85 | -39.06 |
| Other financial income | 0.01 | ||||
| Other financial expenses | -18.92 | 9.72 | -9.34 | -3.86 | -12.06 |
| Net income from associates (fin.) | - 786.63 | 431.63 | |||
| Pre-tax profit | -2 144.45 | -2 022.00 | 3.76 | -82.30 | -50.52 |
| Income taxes | 371.43 | 611.60 | |||
| Net earnings | -1 773.02 | -1 410.40 | 3.76 | -82.30 | -50.52 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 295.27 | 384.75 | |||
| Intangible assets total | 295.27 | 384.75 | |||
| Buildings | 96.86 | ||||
| Machinery and equipment | 26.50 | ||||
| Tangible assets total | 123.36 | ||||
| Holdings in group member companies | 1 013.37 | ||||
| Other receivables | 241.82 | ||||
| Investments total | 1 255.19 | ||||
| Long term receivables total | |||||
| Raw materials and consumables | 523.65 | ||||
| Inventories total | 523.65 | ||||
| Current trade debtors | 2 308.88 | 125.00 | |||
| Current other receivables | 733.74 | 125.25 | 138.82 | 33.22 | 22.64 |
| Current deferred tax assets | 371.43 | 611.60 | |||
| Short term receivables total | 3 414.05 | 736.85 | 263.82 | 33.22 | 22.64 |
| Balance sheet total (assets) | 5 316.25 | 736.85 | 263.82 | 328.49 | 407.39 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 158.70 | 158.70 | 158.70 | 158.70 | 158.70 |
| Other reserves | 230.31 | 300.10 | |||
| Retained earnings | 3 251.94 | 1 478.92 | 68.52 | - 158.03 | - 310.12 |
| Profit of the financial year | -1 773.02 | -1 410.40 | 3.76 | -82.30 | -50.52 |
| Shareholders equity total | 1 637.62 | 227.22 | 230.98 | 148.69 | 98.17 |
| Non-current accruals and deferred income | 345.72 | ||||
| Non-current other liabilities | 981.25 | ||||
| Non-current liabilities total | 1 326.97 | ||||
| Current loans from credit institutions | 450.00 | ||||
| Other non-interest bearing current liabilities | 1 713.09 | 509.63 | 32.84 | 179.80 | 309.22 |
| Accruals and deferred income | 188.57 | ||||
| Current liabilities total | 2 351.66 | 509.63 | 32.84 | 179.80 | 309.22 |
| Balance sheet total (liabilities) | 5 316.25 | 736.85 | 263.82 | 328.49 | 407.39 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.